Singapore HSA registration DE0505205
Novax Pharma Navilipo Eye Drops
Singapore·CLASS B·Novax Pharma S.A.M·Registered December 07, 2020Device classification
- Device Class
- CLASS B
- Medical Speciality Area
- Ophthalmology
Registration information
- Registration Number
- DE0505205
- Registration Date
- December 07, 2020
- Change Notification Approval Date
- November 18, 2022
- Retention Due Date
- December 06, 2025
Product description
Navi®Lipo eye drops helps restoring the ocular surface microenvironment altered by the increased tendency to evaporate, instability of tear film, traumas, ocular surgery, wearing contact lenses, staring at a computer or smartphone screen for a long time
Product Owner
- Short Name
- Novax Pharma S.A.M
- Address
- Le Coronado 20, avenue de Fontvieille, 98000 Monaco, MONACO
Registrant
- Address
- 1 YISHUN INDUSTRIAL STREET 1, A'POSH BIZHUB, #03-32, SINGAPORE 768160
Importer
- Address
- 1 YISHUN INDUSTRIAL STREET 1, A'POSH BIZHUB, #03-32, SINGAPORE 768160
Model information
- Model Name(s)
- Novax Pharma Navilipo Eye Drops 10ml Novax Pharma Navilipo Eye Drops 3ml
- Model Identifier(s)
- D10NL348 D3NL349
About this record
Access comprehensive regulatory information for Novax Pharma Navilipo Eye Drops in the Singapore medical device market through Pure Global AI's free database. This CLASS B medical device is registered under HSA registration number DE0505205 and owned by Novax Pharma S.A.M. The device was registered on December 07, 2020.
This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.
Free DatabasePowered by Pure Global AIHSA Official DataCLASS B